MeritValue

HEALTHY EXTRACTS INC.

HYEXdata completeness 75%11 fiscal years on file

Data notes: no data for concept 'totalDebt'; no data for concept 'pretaxIncome'

The thesis, from the filings

HEALTHY EXTRACTS INC. earns about -120% on equity, and has bought back 95% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$1.68M1$2.25M2$2.49M3$3.11M4$4.51M4
Net income−$1.99M5−$983,1216−$2.47M7−$840,6718−$881,1198
Operating cash flow−$901,2989−$390,62110−$415,74911$281,96812$165,52012
Capital expenditure$013$7,98714$014——
Free cash flow (derived)−$901,2989−$398,60810−$415,74911——
Total debt—————
Cash & equivalents$222,09815$65,65116$19,44117$112,02017$146,93517
Diluted shares338.4M2.9M3.0M3.0M16.9M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
$14.24
your share of equity
Profit it earned you last year
−$0.52
Free cash flow it threw off
—
Debt you’d be carrying
—

10 shares is a claim on $14.24 of net worth that earned you −$0.52 last year.

iii. Is this a good business?
Moat signal · return on equity
-120% avg · 5y
FY21 -80%FY22 -53%FY23 -259%FY24 -205%FY25 -4%

It earned an average -120% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−95% shares · 5y

Share count is down 95% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001096906-23-000699 (Revenues)
  2. 10-K · period ending 2022-12-31 · accession 0001096906-24-000706 (Revenues)
  3. 10-K/A · period ending 2023-12-31 · accession 0001096906-25-000553 (Revenues)
  4. 10-K · period ending 2024-12-31 · accession 0001096906-26-000515 (Revenues)
  5. 10-K · period ending 2021-12-31 · accession 0001096906-23-000699 (NetIncomeLoss)
  6. 10-K · period ending 2022-12-31 · accession 0001096906-24-000706 (NetIncomeLoss)
  7. 10-K/A · period ending 2023-12-31 · accession 0001096906-25-000553 (NetIncomeLoss)
  8. 10-K · period ending 2024-12-31 · accession 0001096906-26-000515 (NetIncomeLoss)
  9. 10-K · period ending 2021-12-31 · accession 0001096906-23-000699 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2022-12-31 · accession 0001096906-24-000706 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K/A · period ending 2023-12-31 · accession 0001096906-25-000553 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2024-12-31 · accession 0001096906-26-000515 (NetCashProvidedByUsedInOperatingActivities)
  13. 10-K · period ending 2021-12-31 · accession 0001096906-23-000699 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K · period ending 2022-12-31 · accession 0001096906-24-000706 (PaymentsToAcquirePropertyPlantAndEquipment)
  15. 10-K · period ending 2021-12-31 · accession 0001096906-24-000706 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
  16. 10-K/A · period ending 2022-12-31 · accession 0001096906-25-000553 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
  17. 10-K · period ending 2023-12-31 · accession 0001096906-26-000515 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)